<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01921374</url>
  </required_header>
  <id_info>
    <org_study_id>DMDK</org_study_id>
    <nct_id>NCT01921374</nct_id>
  </id_info>
  <brief_title>Mother-caregivers of Children With Duchenne Muscular Dystrophy</brief_title>
  <acronym>DMDK</acronym>
  <official_title>Profile of Mother-caregivers of Children With Duchenne Muscular Dystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Monica Levy Andersen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The incidence of Duchenne Muscular Dystrophy (DMD) is approximately 1 in 3.500 male newborns.
      During its progression there is loss of mobility, swallowing difficulties and a significant
      reduction in respiratory capacity. Due to the severity and consequences, is inevitable the
      need for a caregiver, that normally rely the mother.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Duchenne Muscular Dystrophy (DMD) is a neuromuscular disease characterized by genetic
      alteration, whose consequence is the progression of muscle degeneration. The mother-caregiver
      dedicates herself entirely to her son, putting aside the care of their physical and
      psychological health. The responsibility and workload to care for the child is high. Because
      of this extreme amount of work associated with other factors such as stress, this
      mothers-caregivers are more likely to develop hypertension, respiratory disease,
      susceptibility to infections, depression, anxiety, insomnia, impaired immune and
      cardiovascular problems. Moreover, they are more likely to develop sleep disorders, those who
      may cause a high health risk, since many sleep disorders are related to cardiovascular,
      respiratory, neurological and immune systems.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>sleep patterns of the study population</measure>
    <time_frame>Baseline</time_frame>
    <description>Since the mother-caregiver dedicates herself entirely to her son, we will performe overnight polysomnography to assess the sleep pattern.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hormonal profile</measure>
    <time_frame>Baseline</time_frame>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters:
Insulin Cortisol Luteinizing hormone (LH) Follicle-stimulating hormone (FSH) Total Testosterone Estradiol Progesterone Vitamin B12 Adrenocorticotropic hormone (ACTH)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory profile</measure>
    <time_frame>Baseline</time_frame>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters:
C-reactive protein (PCR) Immunoglobulin A (IgA) Immunoglobulin G (IgG) Immunoglobulin M (IgM) Complement (C3) Complement (C4) Interleukin 6 Interleukin 10 Interleukin 1β Interleukin 2 Interleukin 4 Interleukin 8 Interferon-gamma (IFN-γ) Endothelin Prostaglandin E2 Intercellular Adhesion Molecule 1 (ICAM) Vascular cell adhesion protein 1 (VCAM) Tumor necrosis factor (TNFα) Adiponectin Leptin Cysteine Lymphocytes subpopulations (T e B)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular profile</measure>
    <time_frame>Baseline</time_frame>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters:
Homocysteine Myoglobin Cardiac troponin I Creatine kinase (CK) Creatine kinase MB (CKMB)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic profile</measure>
    <time_frame>Baseline</time_frame>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters:
Glucose Total cholesterol and fractions Triglycerides Uric acid Creatinine Urea Sodium Potassium Hemogram Erythrocyte sedimentation rate Natriuretic Peptide B</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Other Diseases or Conditions</condition>
  <arm_group>
    <arm_group_label>sleep parameters</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To assess the sleep parameters.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cardiovascular parameters</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>To assess the cardiovascular profile of control mothers and caregivers-mothers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>imflammatory and immunological profile</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To assess the inflammatory profile of caregivers-mothers and control mothers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hormonal profile</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To assess the hormonal profile of caregivers-mothers and control mothers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>metabolic profile</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To assess the health profile of caregivers-mothers and control mothers.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>sleep parameters</intervention_name>
    <description>Since the mother-caregiver dedicates herself entirely to her son, we will performe overnight polysomnography to assess the sleep pattern.</description>
    <arm_group_label>sleep parameters</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Hormonal profile</intervention_name>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters.</description>
    <arm_group_label>hormonal profile</arm_group_label>
    <other_name>Insulin</other_name>
    <other_name>Cortisol</other_name>
    <other_name>Luteinizing hormone (LH)</other_name>
    <other_name>Follicle-stimulating hormone (FSH)</other_name>
    <other_name>Total Testosterone</other_name>
    <other_name>Estradiol</other_name>
    <other_name>Progesterone</other_name>
    <other_name>Vitamin B12</other_name>
    <other_name>Adrenocorticotropic hormone (ACTH)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Inflammatory profile</intervention_name>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters</description>
    <arm_group_label>imflammatory and immunological profile</arm_group_label>
    <other_name>C-reactive protein (PCR)</other_name>
    <other_name>Immunoglobulin A (IgA)</other_name>
    <other_name>Immunoglobulin G (IgG)</other_name>
    <other_name>Immunoglobulin M (IgM)</other_name>
    <other_name>Complement (C3)</other_name>
    <other_name>Complement (C4)</other_name>
    <other_name>Interleukin 6</other_name>
    <other_name>Interleukin 10</other_name>
    <other_name>Interleukin 1β</other_name>
    <other_name>Interleukin 2</other_name>
    <other_name>Interleukin 4</other_name>
    <other_name>Interleukin 8</other_name>
    <other_name>Interferon-gamma (IFN-γ)</other_name>
    <other_name>Endothelin</other_name>
    <other_name>Prostaglandin E2</other_name>
    <other_name>Intercellular Adhesion Molecule 1 (ICAM)</other_name>
    <other_name>Vascular cell adhesion protein 1 (VCAM)</other_name>
    <other_name>Tumor necrosis factor (TNFα)</other_name>
    <other_name>Adiponectin</other_name>
    <other_name>Leptin</other_name>
    <other_name>Cysteine</other_name>
    <other_name>Lymphocytes subpopulations (T e B)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Cardiovascular profile</intervention_name>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters</description>
    <arm_group_label>cardiovascular parameters</arm_group_label>
    <other_name>Homocysteine</other_name>
    <other_name>Myoglobin</other_name>
    <other_name>Cardiac troponin I</other_name>
    <other_name>Creatine kinase (CK)</other_name>
    <other_name>Creatine kinase MB (CKMB)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Metabolic profile</intervention_name>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters</description>
    <arm_group_label>metabolic profile</arm_group_label>
    <other_name>Glucose</other_name>
    <other_name>Total cholesterol and fractions</other_name>
    <other_name>Triglycerides</other_name>
    <other_name>Uric acid</other_name>
    <other_name>Creatinine</other_name>
    <other_name>Urea</other_name>
    <other_name>Sodium</other_name>
    <other_name>Potassium</other_name>
    <other_name>Hemogram</other_name>
    <other_name>Erythrocyte sedimentation rate</other_name>
    <other_name>Natriuretic Peptide B</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mothers-caregivers of children and adolescents with DMD

          -  Mothers of children and adolescents without any neuromuscular disease and that does
             not have any chronic disease (bronchiolitis obliterates, cystic fibrosis, a genetic
             syndrome)

        Exclusion Criteria:

          -  Volunteers with low levels of education (voluntary functional illiterate) that
             prevents the questionnaires and understanding of the guidelines made

          -  Working mothers of nocturnal period
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Federal of São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>04024001</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.sleepresearchsociety.org/</url>
    <description>Sleep research society</description>
  </link>
  <link>
    <url>http://www.afip.com.br/conteudo.asp?conteudo=22</url>
    <description>Site about Neuromuscular diseases</description>
  </link>
  <reference>
    <citation>Donders J, Taneja C. Neurobehavioral characteristics of children with Duchenne muscular dystrophy. Child Neuropsychol. 2009 May;15(3):295-304. doi: 10.1080/09297040802665777. Epub 2009 Jan 22.</citation>
    <PMID>19160150</PMID>
  </reference>
  <reference>
    <citation>Draper BM, Poulos CJ, Cole AM, Poulos RG, Ehrlich F. A comparison of caregivers for elderly stroke and dementia victims. J Am Geriatr Soc. 1992 Sep;40(9):896-901.</citation>
    <PMID>1512385</PMID>
  </reference>
  <reference>
    <citation>Fee RJ, Hinton VJ. Resilience in children diagnosed with a chronic neuromuscular disorder. J Dev Behav Pediatr. 2011 Nov;32(9):644-50. doi: 10.1097/DBP.0b013e318235d614.</citation>
    <PMID>22008789</PMID>
  </reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2013</study_first_submitted>
  <study_first_submitted_qc>August 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2013</study_first_posted>
  <last_update_submitted>February 2, 2016</last_update_submitted>
  <last_update_submitted_qc>February 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Monica Levy Andersen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Duchenne;</keyword>
  <keyword>mothers caregivers;</keyword>
  <keyword>sleep;</keyword>
  <keyword>hormonal profile;</keyword>
  <keyword>cardiac profile;</keyword>
  <keyword>biochemical profile;</keyword>
  <keyword>inflammatory profile.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Muscular Dystrophy, Duchenne</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Testosterone</mesh_term>
    <mesh_term>Progesterone</mesh_term>
    <mesh_term>Follicle Stimulating Hormone</mesh_term>
    <mesh_term>Adrenocorticotropic Hormone</mesh_term>
    <mesh_term>Melanocyte-Stimulating Hormones</mesh_term>
    <mesh_term>Immunoglobulins</mesh_term>
    <mesh_term>Antibodies</mesh_term>
    <mesh_term>Complement System Proteins</mesh_term>
    <mesh_term>Immunoglobulin G</mesh_term>
    <mesh_term>Immunoglobulin A</mesh_term>
    <mesh_term>Interleukin-4</mesh_term>
    <mesh_term>Immunoglobulin M</mesh_term>
    <mesh_term>Interleukin-2</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
    <mesh_term>Interferon-gamma</mesh_term>
    <mesh_term>beta-Endorphin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

